[Remote] Medical Science Liaison - Ankara at Eli Lilly and Company

Turkiye

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Candidates should possess a Doctor of Pharmacy (PharmD), Bachelor of Pharmacy (BPharm), Medical Degree (MD), or a Doctor of Philosophy (PhD) in a medically related field, or a Master’s or Bachelor’s degree in health sciences with at least one or more years of clinical, research, or industry experience, preferably in Diabetes. A Master’s degree in health sciences is desirable, and preference will be given to candidates with an MD or PhD.

Responsibilities

The Medical Science Liaison will maintain and effectively communicate deep scientific knowledge within their therapeutic area, engaging in continuous learning to ensure technical expertise. They will establish themselves as a reliable resource for unbiased, accurate, and up-to-date medical and scientific knowledge, engaging in customer-facing dialogues with scientific experts and providing support for their information needs. Additionally, the MSL will act as the primary interface between Lilly and scientific experts, delivering a best-in-class customer experience and facilitating scientific exchange between industry and the scientific community.

Skills

PharmD

BPharm

PhD

Health Sciences

BSN

RPh

Clinical Research

Industry Medical/Scientific Role

Diabetes

Chronic Weight Management

Medical Education

Scientific Exchange

Field-Based Medical Professional

Therapeutic Areas

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free